Hurthle cell thyroid (HCT) cancer is a rare and aggressive form of thyroid cancer that has a tendency to spread to other parts of the body. Due to the rarity of HCT cancer, researchers continue to ...

National Cancer Institute (NCI) dose response curves for PT162 against multiple cancers are demonstrated on the graphs Newly Patented PT162 Induces Cancer Cell Cycle Arrest and/or Apoptosis by ...

Results of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show that adding an immunomodulatory agent to treatment with the targeted ...

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in oncology toward harnessing the immune system's intrinsic ability to combat ...

The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found. The study, led by Dr. Rod Bremner, a Senior Investigator at the ...

Thyroid cancer is becoming increasingly common worldwide. In India, incidence has risen significantly, by 62 per cent among ...

ASHLEY: IT’S NOT EXACTLY CLEAR WHY, BUT WOMEN ARE THREE TIMES MORE LIKELY THAN MEN TO BE DIAGNOSED WITH THYROID CANCER. THAT’S TODAY’S WOMAN’S DOCTOR. THE THYROID IS A SMALL BUTTERFLY OR SHIELD SHAPED ...